Food and Staples Retailing Drug Retail

More

  • Valeant bets on pink pill Thursday, 20 Aug 2015 | 3:24 PM ET
    Valeant bets on pink pill

    Shares of Valeant are down 6 percent after buying Sprout Pharmaceuticals, the maker of the "female Viagra" drug. CNBC's Meg Tirrell discusses drug deals.

  • 'Female Viagra' sparks interest in Valeant Thursday, 20 Aug 2015 | 8:00 AM ET
    'Female Viagra' sparks interest in Valeant

    Valeant to purchase flibanserin-maker Sprout for $1 billion.

  • 'Female Viagra' hits the markets this fall Wednesday, 19 Aug 2015 | 10:00 AM ET
    'Female Viagra' hits the markets this fall

    The FDA approved the first prescription drug for enhancing female libido.

  • Wal-Mart Stores Inc said on Tuesday that lower margins in its pharmacy business had emerged as a drag on profits, as it gets paid less by drug plan managers and as fewer customers pay in cash, since Obamacare has increased the ranks of insured Americans. The company warned that the margin squeeze would continue for at least the remainder of the year, although a...

  • Aug 18- Wal-Mart Stores Inc reported weaker quarterly earnings and lowered its annual forecast on Tuesday, as it copes with higher labor costs, a squeeze on pharmacy margins and sliding sales at its British supermarket chain. Net profit attributable to Wal-Mart fell to $3.48 billion, or $1.08 per share, in the second quarter ended July 31, from $3.92 billion, or...

  • Aug 18- Wal-Mart Stores Inc reported weaker-than-expected quarterly earnings and lowered its annual forecast on Tuesday, citing higher costs from adding worker hours as well as weaker margins in its U.S. pharmacy business. Wal-Mart lowered its forecast for the year ending in January to a range of $4.40 to $4.70 from its outlook of $4.70 to $5.05 in February.

  • Aug 18- Wal-Mart Stores Inc reported weaker-than-expected quarterly earnings and lowered its full-year forecast, citing higher costs from adding worker hours as well as weaker margins in its U.S. pharmacy business. For the year ending in January, Wal-Mart lowered its earnings-per-share forecast to a range of $4.40 to $4.70 from its outlook of $4.70 to $5.05...

  • Aug 18- Wal-Mart Stores Inc reported weaker-than-expected quarterly earnings and lowered its full-year forecast on Tuesday, citing investments in staffing and weaker margins in its U.S. pharmacy business. Net profit attributable to Wal-Mart fell to $1.08 per share, in the second quarter ended July 31 from $1.21 per share, a year earlier.

  • The Spark: FDA approves first 3-D printed drugs Thursday, 13 Aug 2015 | 4:50 PM ET
    The Spark: FDA approves first 3-D printed drugs

    Don Weatherhold, Aprecia Pharmaceuticals CEO, discusses Aprecia and the technology of 3-D printing and prescription drugs.

  • Rite Aid to accept Apple Pay and Google Wallet Tuesday, 11 Aug 2015 | 5:25 PM ET
    Apple Pay

    The drugstore is expanding to accept Apple Pay and Google Wallet Saturday after slashing support last year. Re/code reports.

  • Mobile payments for Rite Aid Tuesday, 11 Aug 2015 | 10:00 AM ET
    Mobile payments for Rite Aid

    Rite Aid to start accepting mobile payments this Saturday.

  • CVS drops Pfizer's Viagra Wednesday, 5 Aug 2015 | 1:14 PM ET
    CVS drops Pfizer's Viagra

    CVS says Pfizer's Viagra will no longer be an approved formula in 2016, reports CNBC's Bertha Coombs.

  • Viagra shot? China probes sex drug-spiked liquor Sunday, 2 Aug 2015 | 8:38 PM ET
    Viagra pill

    Chinese police are investigating if two distillers added impotence treatment drug Viagra to their liquor in the latest food-safety scare in China.

  • Doctors fight to lower cancer drugs cost Friday, 24 Jul 2015 | 3:19 PM ET
    Doctors fight to lower cancer drugs cost

    Amid rising health care and drug costs, a group of doctors at the Mayo Clinic is trying to lower the costs of cancer treatments for patients. Insight, with Dr. Ayalew Tefferi, Mayo Clinic.

  • What to expect from US June retail sales Monday, 13 Jul 2015 | 6:19 PM ET
    What to expect from US June retail sales

    Lindsey Bell, Senior Analyst at S&P Capital IQ, explains why she's expecting a monthly increase of 0.3 percent.

  • Medical marijuana coming to New York state Monday, 15 Jun 2015 | 6:46 AM ET
    Medical marijuana coming to New York state

    New Yorkers suffering from cancer, epilepsy, Crohn's disease and Parkinson's disease may soon be able to access medical marijuana in the state. Jason Cranford, expert botanist and Director of Cultivation at the Compassionate Care Center of New York, provides insight.

  • New Alzheimer's drugs timeline Friday, 12 Jun 2015 | 1:05 PM ET
    New Alzheimer's drugs timeline

    How Alzheimer's drug Solanezumab works to help treat the underlying cause of the disease, with CNBC's Meg Tirrell.

  • The Fed's wholesale issue with Costco Friday, 5 Jun 2015 | 10:00 AM ET
    The Fed's wholesale issue with Costco

    Costco has been subpoenaed by the federal government concerning prescriptions for controlled substances.

  • Helping doctors share cancer research Tuesday, 2 Jun 2015 | 1:18 PM ET
    Helping doctors share cancer research

    CNBC's Meg Tirrell provides insight to what Foundation Medicine, a cancer testing company, can do to better inform doctors on cancer via a database filled with research.

  • Two parts of Express Scripts' new plan Wednesday, 27 May 2015 | 1:01 PM ET
    Two parts of Express Scripts' new plan

    A new plan for Express Scripts regarding cancer drugs, with CNBC's Meg Tirrell.